Faruqi & Faruqi, LLP Announces Shareholder Investigation Related to the Acquisition of Drugstore.com Inc. - DSCM
March 25 2011 - 4:37PM
Business Wire
Faruqi & Faruqi, LLP, a leading national securities firm
headquartered in New York City, is investigating the Board of
Directors of Drugstore.com Inc. (“Drugstore.com” or the “Company”)
(NasdaqGS: DSCM) for potential breaches of fiduciary duties in
connection with their conduct related to the sale of the Company to
Walgreen Co. (NYSE: WAG) for approximately $429 million in cash.
The proposed transaction only offers Drugstore.com shareholders
$3.80 in cash for each Drugstore.com share they hold.
Request more information now by clicking here:
www.faruqilaw.com/DSCM
Whether the Drugstore.com’s Board of Directors breached their
fiduciary duties to Drugstore.com’s stockholders by failing to
conduct an adequate and fair sales process to sell the Company
prior to agreeing to this proposed transaction, whether the
proposed transaction undervalues Drugstore.com’s shares and by how
much this proposed transaction undervalues the Company to the
detriment of Drugstore.com shareholders are the key focus of this
investigation.
Faruqi & Faruqi, LLP is a national law firm which represents
investors and individuals in class action litigation. The firm is
focused on providing exemplary legal services in complex litigation
in the areas of securities, shareholder, antitrust and consumer
litigation, through all phases of litigation. The firm has an
experienced trial team which has achieved significant victories on
behalf of the firm’s clients.
If you own common stock in Drugstore.com and wish to obtain
additional information, please visit us at www.faruqilaw.com/DSCM
or contact Juan E. Monteverde, Esq. either via e-mail at
jmonteverde@faruqilaw.com or by telephone at (877) 247-4292 or
(212) 983-9330.
Attorney Advertising. (C) 2011 Faruqi & Faruqi, LLP. The law
firm responsible for this advertisement is Faruqi & Faruqi, LLP
(www.faruqilaw.com). Prior results do not guarantee or predict a
similar outcome with respect to any future matter. We are happy to
discuss your particular case.
Drugstore (NASDAQ:DSCM)
Historical Stock Chart
From Oct 2024 to Nov 2024
Drugstore (NASDAQ:DSCM)
Historical Stock Chart
From Nov 2023 to Nov 2024